YOLFTbeta
Milestone Scientific

Milestone Scientific

MLSS · AMEX · Healthcare / Medical Instruments & Supplies

0.307USD+0.02 (+5.86%)

Price History

Full chart

Market Stats

Previous Close0.29
Open0.2874
Day Range0.287 – 0.317
52-Week Range0.2181 – 0.60
Volume146.27K
Market Cap37.15M
P/E (TTM)0.00
Forward P/E18.21
EPS-0.05
Dividend Yield0.00%
Beta1.07
50-Day Avg0.448
200-Day Avg0.3506

About

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Eric C. Hines
  • Employees15
  • Headquarters425 Eagle Rock Avenue, Roseland, NJ, United States, 07068, USA
  • Websitehttps://www.milestonescientific.com

Leadership

  • Ms. Benedetta I. CasamentoExecutive Chairman · b. 1967
  • Mr. Eric C. HinesCEO, President & Director · b. 1968
  • Mr. Leonard A. OsserFounder · b. 1947
  • Ms. Keisha Harcum M.B.A., M.S.Vice President of Finance
  • Mr. Jason PapesSenior VP and Global Head of Sales & Marketing

Financials

Income Statement

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue300.00K2.90M8.80M2.86M5.67M4.09M4.07M3.97M4.75M6.43M5.84M6.39M6.62M8.55M9.75M8.38M8.65M10.01M10.33M9.49M10.48M11.28M9.62M8.37M5.44M10.30M8.81M9.83M8.63M8.97M
Growth (%)-+866.67%+203.45%-67.55%+98.72%-27.86%-0.48%-2.51%+19.63%+35.40%-9.16%+9.35%+3.65%+29.07%+14.05%-14.07%+3.22%+15.76%+3.21%-8.14%+10.43%+7.63%-14.71%-12.97%-35.07%+89.52%-14.54%+11.60%-12.19%+3.99%
Cost of Revenue-1.60M9.60M839.46K2.91M1.97M1.98M2.00M2.42M2.52M3.04M2.90M2.68M3.46M3.53M3.02M3.06M3.20M3.63M3.05M4.18M4.31M5.19M2.66M1.82M3.99M3.91M3.03M2.20M2.64M
Gross Profit300.00K1.30M-800.00K2.02M2.77M2.12M2.09M1.97M2.34M3.91M2.81M3.49M3.94M5.09M6.22M5.36M5.59M6.81M6.70M6.44M6.31M6.97M4.43M5.72M3.62M6.31M4.90M6.79M6.43M6.33M
Gross Margin100.00%44.83%-9.09%70.60%48.75%51.80%51.38%49.56%49.15%60.81%48.06%54.65%59.52%59.55%63.78%63.99%64.66%68.05%64.86%67.88%60.16%61.77%46.05%68.28%66.60%61.25%55.65%69.12%74.56%70.53%
Operating Expense2.60M9.00M10.20M8.20M9.60M5.32M3.76M3.70M5.34M7.16M6.33M6.73M5.67M7.19M6.92M6.59M6.11M5.73M7.49M9.50M12.82M12.20M12.43M9.72M11.07M13.69M13.73M13.90M13.19M12.03M
Operating Income-2.30M-7.70M-11.00M-6.18M-6.84M-3.20M-1.67M-1.73M-3.01M-3.25M-3.52M-3.24M-1.73M-2.10M-700.84K-1.22M-520.35K1.09M-790.18K-3.06M-6.51M-5.23M-8.00M-4.00M-7.45M-7.38M-8.83M-7.11M-6.76M-5.70M
Operating Margin-766.67%-265.52%-125.00%-216.49%-120.48%-78.18%-40.98%-43.61%-63.31%-50.47%-60.28%-50.70%-26.10%-24.61%-7.19%-14.60%-6.02%10.85%-7.65%-32.20%-62.14%-46.40%-83.14%-47.75%-137.08%-71.60%-100.24%-72.31%-78.30%-63.48%
EBITDA-2.10M-7.20M-10.50M-5.45M-6.12M-2.77M-1.25M-1.40M-2.91M-3.13M-3.52M-3.24M-1.73M-2.10M-572.20K-1.24M-596.20K1.18M-694.34K-2.96M-6.35M-4.66M-5.58M-7.39M-7.36M-6.79M-8.71M-6.92M-4.68M-5.51M
EBITDA Margin-700.00%-248.28%-119.32%-190.82%-107.82%-67.55%-30.72%-35.17%-61.17%-48.64%-60.28%-50.70%-26.10%-24.61%-5.87%-14.80%-6.89%11.81%-6.72%-31.18%-60.59%-41.32%-57.97%-88.21%-135.31%-65.85%-98.90%-70.40%-54.19%-61.41%
Net Income-1.90M-7.40M-10.70M-6.97M-7.51M-3.99M-2.44M-2.41M-3.00M-2.75M-3.15M-2.94M-1.19M-1.53M-614.51K-1.48M-870.31K1.46M-1.70M-5.47M-5.95M-5.19M-7.43M-7.52M-7.34M-6.82M-8.71M-6.93M-4.71M-5.72M
Net Income Margin-633.33%-255.17%-121.59%-244.17%-132.35%-97.51%-59.90%-60.75%-63.08%-42.81%-53.94%-45.98%-17.93%-17.90%-6.30%-17.69%-10.06%14.63%-16.47%-57.60%-56.73%-45.97%-77.24%-89.85%-134.94%-66.17%-98.87%-70.51%-54.62%-63.76%
R&D200.00K1.00M400.00K455.33K386.25K49.94K147.71K131.01K187.99K286.26K1.01M397.35K168.52K241.32K270.49K140.05K181.98K191.34K88.24K100.86K1.27M272.75K245.64K189.92K307.85K878.21K1.15M701.38K858.77K449.47K
R&D as % of Total Revenue66.67%34.48%4.55%15.95%6.81%1.22%3.63%3.30%3.96%4.45%17.20%6.22%2.54%2.82%2.77%1.67%2.10%1.91%0.85%1.06%12.12%2.42%2.55%2.27%5.66%8.52%13.06%7.14%9.95%5.01%
Interest Expense000000000000116.37K154.03K95.14K131.84K178.97K70.80K2.67K01.28K007.14M18.08K16.36K54.61K--25.60K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.76%1.80%0.98%1.57%2.07%0.71%0.03%0.00%0.01%0.00%0.00%85.29%0.33%0.16%0.62%--0.29%

Balance Sheet

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.70M20.00M9.20M5.62M2.55M1.52M1.24M1.72M5.37M7.05M5.14M4.99M4.41M4.85M6.61M6.99M5.66M8.06M17.48M12.81M13.55M15.63M6.40M6.56M19.57M19.81M13.70M11.37M9.80M7.81M
Total Liabilities700.00K1.50M900.00K3.49M4.26M5.97M7.35M4.16M848.62K731.39K1.43M3.45M3.01M2.21M4.28M5.06M3.72M2.54M2.44M3.64M5.01M8.13M4.87M4.93M3.46M3.59M3.70M3.36M3.96M4.99M
Total Equity4.00M18.50M8.30M2.13M-1.70M-4.46M-6.11M-2.44M4.52M6.32M3.71M1.54M1.40M2.64M2.33M1.94M1.94M5.52M14.65M10.31M8.50M7.24M1.54M1.70M16.20M16.37M10.23M8.01M5.83M2.81M
Cash800.00K9.80M300.00K242.84K172.87K15.74K9.68K3.28K3.04M2.89M1.16M745.00K743.66K1.03M627.08K96.32K165.25K1.15M10.37M4.19M3.60M2.64M743.43K1.52M14.22M14.76M8.72M2.98M3.26M1.11M
Total Debt100.00K200.00K200.00K2.25M2.60M3.75M5.36M1.54M---934.63K1.69M438.84K441.64K446.94K806.56K50.00K50.00K----15.98K942.60K586.59K497.04K395.98K349.05K1.02M
Net Debt-700.00K-9.60M-100.00K2.01M2.43M3.74M5.35M1.54M-3.04M-2.89M-1.16M189.63K941.88K-590.29K-185.44K350.61K284.75K-1.10M-10.32M-4.19M-3.60M-2.64M-743.43K-1.50M-13.28M-14.18M-8.22M-2.58M-2.91M-92.40K

Cash Flow

Currency: USD1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.50M-4.70M-8.60M-5.33M-2.84M-1.38M-676.18K-820.59K-4.28M-3.27M-1.65M-1.15M-442.01K402.95K-293.78K-570.73K-49.72K1.26M376.94K-2.95M-5.40M-1.23M-1.63M-1.78M-6.98M-4.02M-6.03M-5.33M-2.92M-2.92M
Investing Cash Flow-100.00K-6.30M-1.10M3.16M-51.77K-10.67K-74.34K-35.27K-496.02K-335.77K-81.84K-335.64K-309.33K-144.35K-108.27K-39.03K-31.36K-561.39K-1.30M-3.73M8.21K-199.18K-15.42K-9.92K-21.44K-15.19K-8.53K-2.97M2.97M-15.12K
Financing Cash Flow-19.90M300.00K2.10M2.82M1.24M744.46K849.45K7.82M3.45M-1.07M750.00K26.87K-79.00K150.00K284.60K10.15M500.00K4.80M463.34K-250.00K2.56M19.71M4.57M-8.54K2.56M233.77K786.34K
Capital Expenditure100.00K500.00K3.60M106.81K51.77K10.67K74.34K35.27K350.53K23.09K81.84K335.64K317.08K174.35K110.29K39.03K31.36K26.56K98.96K77.52K30.96K199.18K7.40K9.92K21.44K15.19K8.53K4.88K10.13K15.12K
Free Cash Flow-1.60M-5.20M-12.20M-5.44M-2.89M-1.40M-750.52K-855.86K-4.64M-3.29M-1.73M-1.49M-759.09K228.60K-404.07K-609.76K-81.08K1.23M277.98K-3.02M-5.43M-1.43M-1.64M-1.79M-7.01M-4.03M-6.04M-5.33M-2.93M-2.93M
Dividends Paid---------------0000000--------
FCF to OCF106.67%110.64%141.86%102.00%101.82%100.77%110.99%104.30%108.18%100.71%104.96%129.17%171.74%56.73%137.54%106.84%163.07%97.89%73.75%102.63%100.57%116.20%100.45%100.56%100.31%100.38%100.14%100.09%100.35%100.52%
Dividend Paid to FCF---------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMar 30, 1998May 4, 1998Jun 30, 1998Sep 30, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002May 20, 2003Aug 19, 2003Nov 13, 2003May 17, 2004Aug 16, 2004Nov 14, 2004May 16, 2005Aug 16, 2005Nov 14, 2005May 16, 2006Aug 14, 2006Nov 13, 2006May 17, 2007Aug 17, 2007Nov 14, 2007May 15, 2008Aug 14, 2008Nov 14, 2008May 8, 2009Aug 11, 2009Nov 12, 2009May 13, 2010Aug 11, 2010Nov 15, 2010May 9, 2011Aug 10, 2011Nov 11, 2011Mar 13, 2012May 14, 2012Aug 10, 2012Nov 15, 2012Mar 14, 2013May 7, 2013Aug 9, 2013Nov 13, 2013Mar 13, 2014May 14, 2014Aug 14, 2014Nov 13, 2014May 14, 2015Aug 13, 2015Nov 11, 2015Mar 30, 2016May 17, 2016Aug 11, 2016Nov 9, 2016Mar 31, 2017May 15, 2017Aug 14, 2017Nov 14, 2017May 15, 2018Aug 14, 2018Nov 14, 2018Dec 31, 2018May 14, 2019Aug 14, 2019Nov 14, 2019Mar 30, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 31, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 30, 2023May 10, 2023Aug 14, 2023Nov 14, 2023Mar 29, 2024May 15, 2024Aug 14, 2024Nov 14, 2024Mar 27, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Mar 27, 2026May 13, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate-0.600.00-----------------------------0.05-0.04---------------------0.01-----0.02-0.02-0.01-0.02-0.05-0.06-0.05-0.04-0.02-0.05-0.04-0.04-0.04-0.02-0.01-0.02-0.02-0.04-0.04-0.02-0.02-0.02-0.03-0.03-0.03-0.03-0.03-0.03-0.03-0.02-0.02-0.02-0.02-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01
EPS Actual-1.560.12-1.09-0.89-0.54-0.54-0.52-0.36-0.31-0.29-0.37-0.30-0.22-0.13-0.12-0.14-0.12-0.15-0.15-0.07-0.09-0.11-0.09-0.07-0.05-0.06-0.08-0.05-0.04-0.09-0.08-0.05-0.04-0.01-0.05-0.05-0.030.010.01-0.04-0.01-0.02-0.04-0.03-0.02-0.010.00-0.020.010.000.010.050.01-0.01-0.02-0.02-0.09-0.07-0.07-0.03-0.06-0.05-0.06-0.02-0.05-0.04-0.06-0.04-0.120.01-0.02-0.02-0.06-0.05-0.03-0.06-0.02-0.01-0.01-0.04-0.03-0.02-0.03-0.04-0.03-0.03-0.02-0.03-0.02-0.03-0.02-0.02-0.02-0.03-0.02-0.02-0.01-0.01-0.01-0.01-
Surprise-160.00%------------------------------60.00%-25.00%----------------------200.00%-----250.00%-50.00%-500.00%-150.00%-20.00%66.67%0.00%0.00%-200.00%20.00%-200.00%125.00%50.00%0.00%-500.00%-150.00%-50.00%-50.00%50.00%50.00%50.00%-100.00%0.00%33.33%0.00%-33.33%0.00%0.00%33.33%-50.00%0.00%-50.00%0.00%-100.00%-100.00%-200.00%-100.00%-100.00%0.00%0.00%0.00%0.00%-
Timing------------------------------After-hoursAfter-hours---------------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap37.15M
Enterprise Value36.24M
Trailing P/E0.00
Forward P/E18.21
PEG Ratio0.00
Price / Sales3.94
Price / Book10.86
EPS-0.05
Book Value0.039
Revenue (TTM)9.42M
Gross Profit (TTM)6.62M
EBITDA-4.03M
Profit Margin-43.98%
Operating Margin-37.37%
Return on Equity-121.67%
Return on Assets-31.28%
Shares Outstanding90.61M
Shares Float74.89M
Beta1.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 1.25
  • Strong Buy
    1
  • Buy
    1

Stock Splits

  • Jan 14, 20041:3